{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:47:26Z","timestamp":1792511246257,"version":"4.5.0"},"reference-count":131,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T00:00:00Z","timestamp":1501113600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s12016-017-8632-5","type":"journal-article","created":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T13:49:13Z","timestamp":1501163353000},"page":"371-393","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Skin Manifestations of Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, and Spondyloarthritides"],"prefix":"10.1007","volume":"53","author":[{"given":"Carolyn Jean","family":"Chua-Aguilera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkhard","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0024-338X","authenticated-orcid":false,"given":"Nikhil","family":"Yawalkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,27]]},"reference":[{"key":"8632_CR1","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1196\/annals.1351.019","volume":"1069","author":"TK Kvien","year":"2006","unstructured":"Kvien TK, Uhlig T, Odegard S, Heiberg MS (2006) Epidemiological aspects of rheumatoid arthritis: the sex ratio. Ann N Y Acad Sci 1069:212\u2013222","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"8632_CR2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0889-857X(05)70323-9","volume":"23","author":"JL Nelson","year":"1997","unstructured":"Nelson JL, Ostensen M (1997) Pregnancy and rheumatoid arthritis. Rheum Dis Clin N Am 23(1):195\u2013212","journal-title":"Rheum Dis Clin N Am"},{"issue":"3","key":"8632_CR3","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s10067-017-3547-3","volume":"36","author":"D Alpizar-Rodriguez","year":"2017","unstructured":"Alpizar-Rodriguez D, Brulhart L, Mueller RB, Moller B, Dudler J, Ciurea A et al (2017) The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis. Clin Rheumatol 36(3):677\u2013682","journal-title":"Clin Rheumatol"},{"issue":"1","key":"8632_CR4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/14397595.2013.854059","volume":"24","author":"H Yamanaka","year":"2014","unstructured":"Yamanaka H, Sugiyama N, Inoue E, Taniguchi A, Momohara S (2014) Estimates of the prevalence of and current treatment practices for rheumatoid arthritis in Japan using reimbursement data from health insurance societies and the IORRA cohort (I). Mod Rheumatol 24(1):33\u201340","journal-title":"Mod Rheumatol"},{"issue":"5","key":"8632_CR5","doi-asserted-by":"crossref","first-page":"A288","DOI":"10.1016\/j.autrev.2009.11.019","volume":"9","author":"GJ Tobon","year":"2010","unstructured":"Tobon GJ, Youinou P, Saraux A (2010) The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis. Autoimmun Rev 9(5):A288\u2013A292","journal-title":"Autoimmun Rev"},{"issue":"Suppl 3","key":"8632_CR6","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1186\/ar578","volume":"4","author":"AJ Silman","year":"2002","unstructured":"Silman AJ, Pearson JE (2002) Epidemiology and genetics of rheumatoid arthritis. Arthritis Res 4(Suppl 3):S265\u2013S272","journal-title":"Arthritis Res"},{"issue":"5","key":"8632_CR7","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.semarthrit.2016.10.010","volume":"46","author":"C McDougall","year":"2017","unstructured":"McDougall C, Hurd K, Barnabe C (2017) Systematic review of rheumatic disease epidemiology in the indigenous populations of Canada, the United States, Australia, and New Zealand. Semin Arthritis Rheum 46(5):675\u2013686","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"8632_CR8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.21575","volume":"54","author":"L Klareskog","year":"2006","unstructured":"Klareskog L, Stolt P, Lundberg K, Kallberg H, Bengtsson C, Grunewald J et al (2006) A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 54(1):38\u201346","journal-title":"Arthritis Rheum"},{"issue":"3","key":"8632_CR9","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/art.39491","volume":"68","author":"N Kharlamova","year":"2016","unstructured":"Kharlamova N, Jiang X, Sherina N, Potempa B, Israelsson L, Quirke AM et al (2016) Antibodies to Porphyromonas gingivalis indicate interaction between oral infection, smoking, and risk genes in rheumatoid arthritis etiology. Arthritis Rheumatol 68(3):604\u2013613","journal-title":"Arthritis Rheumatol"},{"key":"8632_CR10","doi-asserted-by":"crossref","unstructured":"Konig MF, Abusleme L, Reinholdt J, Palmer RJ, Teles RP, Sampson K, et al (2016) Aggregatibacter actinomycetemcomitans-induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis. Sci Transl Med. 8(369):369ra176","DOI":"10.1126\/scitranslmed.aaj1921"},{"issue":"2","key":"8632_CR11","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","volume":"50","author":"MM Nielen","year":"2004","unstructured":"Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH et al (2004) Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 50(2):380\u2013386","journal-title":"Arthritis Rheum"},{"issue":"3","key":"8632_CR12","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/ard.2011.149765","volume":"70","author":"DT Felson","year":"2011","unstructured":"Felson DT, Smolen JS, Wells G, Zhang B, van Tuyl LH, Funovits J et al (2011) American College of Rheumatology\/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis 70(3):404\u2013413","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"8632_CR13","first-page":"85","volume":"35","author":"M Genty","year":"2017","unstructured":"Genty M, Combe B, Kostine M, Ardouin E, Morel J, Lukas C (2017) Improvement of fatigue in patients with rheumatoid arthritis treated with biologics: relationship with sleep disorders, depression and clinical efficacy. A prospective, multicentre study. Clin Exp Rheumatol 35(1):85\u201392","journal-title":"Clin Exp Rheumatol"},{"key":"8632_CR14","first-page":"1","volume":"25","author":"TW Nystad","year":"2015","unstructured":"Nystad TW, Fenstad AM, Furnes O, Havelin LI, Skredderstuen AK, Fevang BT (2015) Reduction in orthopaedic surgery in patients with rheumatoid arthritis: a Norwegian register-based study. Scand J Rheumatol 25:1\u20137","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"8632_CR15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van\u2019t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38(1):44\u201348","journal-title":"Arthritis Rheum"},{"issue":"1","key":"8632_CR16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2015-207524","volume":"75","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Breedveld FC, Burmester GR, Bykerk V, Dougados M, Emery P et al (2016) Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis 75(1):3\u201315","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"8632_CR17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/ard.2010.139535","volume":"70","author":"F McQueen","year":"2011","unstructured":"McQueen F, Naredo E (2011) The 'disconnect' between synovitis and erosion in rheumatoid arthritis: a result of treatment or intrinsic to the disease process itself? Ann Rheum Dis 70(2):241\u2013244","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"8632_CR18","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/annrheumdis-2012-202709","volume":"73","author":"B Moller","year":"2014","unstructured":"Moller B, Scherer A, Forger F, Villiger PM, Finckh A, Swiss Clinical Quality Management Program for Rheumatic D (2014) Anaemia may add information to standardised disease activity assessment to predict radiographic damage in rheumatoid arthritis: a prospective cohort study. Ann Rheum Dis 73(4):691\u2013696","journal-title":"Ann Rheum Dis"},{"key":"8632_CR19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jaad.2004.07.023","volume":"53","author":"A Sayah","year":"2005","unstructured":"Sayah A, English JC III (2005) Rheumatoid arthritis: a review of the cutaneous manifestations. J Am Acad Dermatol 53:191\u2013209","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"8632_CR20","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.clindermatol.2006.07.008","volume":"24","author":"T Hata","year":"2006","unstructured":"Hata T, Kavanaugh A (2006) Rheumatoid arthritis in dermatology. Clin Dermatol 24(5):430\u2013437","journal-title":"Clin Dermatol"},{"issue":"9","key":"8632_CR21","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00296-009-0881-z","volume":"29","author":"T Yamamoto","year":"2009","unstructured":"Yamamoto T (2009) Cutaneous manifestations associated with rheumatoid arthritis. Rheumatol Int 29(9):979\u2013988","journal-title":"Rheumatol Int"},{"issue":"2","key":"8632_CR22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.autrev.2011.09.001","volume":"11","author":"M Prete","year":"2011","unstructured":"Prete M, Racanelli V, Digiglio L, Vacca A, Dammacco F, Perosa F (2011) Extra-articular manifestations of rheumatoid arthritis: an update. Autoimmun Rev 11(2):123\u2013131","journal-title":"Autoimmun Rev"},{"issue":"2","key":"8632_CR23","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1468-3083.2005.01118.x","volume":"19","author":"J Knab","year":"2005","unstructured":"Knab J, Goos M, Dissemond J (2005) Successful treatment of a leg ulcer occurring in a rheumatoid arthritis patient under leflunomide therapy. J Eur Acad Dermatol Venereol 19(2):243\u2013246","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"8632_CR24","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","volume":"76","author":"JS Smolen","year":"2017","unstructured":"Smolen JS, Landewe R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M et al (2017) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis 76(6):960\u2013977","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"8632_CR25","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1002\/art.21421","volume":"52","author":"S Wassenberg","year":"2005","unstructured":"Wassenberg S, Rau R, Steinfeld P, Zeidler H (2005) Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum 52(11):3371\u20133380","journal-title":"Arthritis Rheum"},{"key":"8632_CR26","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0002-9343(84)90787-3","volume":"76","author":"BR Kaye","year":"1984","unstructured":"Kaye BR, Kaye RL, Bobrove A (1984) Rheumatoid nodules. Review of the spectrum of associated conditions and proposal of a new classification, with a report of four seronegative cases. Am J Med 76:279\u2013292","journal-title":"Am J Med"},{"issue":"8","key":"8632_CR27","first-page":"1839","volume":"27","author":"H Kato","year":"2000","unstructured":"Kato H, Yamakawa M, Ogino T (2000) Complement mediated vascular endothelial injury in rheumatoid nodules: a histopathological and immunohistochemical study. J Rheumatol 27(8):1839\u20131847","journal-title":"J Rheumatol"},{"issue":"9","key":"8632_CR28","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/art.1780310915","volume":"31","author":"R Segal","year":"1998","unstructured":"Segal R, Caspi D, Tishler M, Fishel B, Yaron M (1998) Accelerated nodulosis and vasculitis during methotrexate therapy for rheumatoid arthritis. Arthritis Rheum 31(9):1182\u20131185","journal-title":"Arthritis Rheum"},{"issue":"5","key":"8632_CR29","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1525-1470.2009.00990.x","volume":"26","author":"R Abdwani","year":"2009","unstructured":"Abdwani R, Scuccumarri R, Duffy K, Duffy CM (2009) Nodulosis in systemic onset juvenile idiopathic arthritis: an uncommon event with spontaneous resolution. Pediatr Dermatol 26(5):587\u2013591","journal-title":"Pediatr Dermatol"},{"issue":"3 Suppl1","key":"8632_CR30","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1590\/abd1806-4841.20153750","volume":"90","author":"CV Kellet","year":"2015","unstructured":"Kellet CV, Navarrete RA, Bombardieri SG, Manriquez J (2015) Azathioprine-induced accelerated cutaneous and pulmonary nodulosis in a patient with rheumatoid arthritis. An Bras Dermatol 90(3 Suppl1):162\u2013164","journal-title":"An Bras Dermatol"},{"issue":"7","key":"8632_CR31","first-page":"1590","volume":"34","author":"A Ede Van","year":"2007","unstructured":"Van Ede A, den Broeder A, Wagenaar M, van Riel P, Creemers MC (2007) Etanercept-related extensive pulmonary nodulosis in a patient with rheumatoid arthritis. J Rheumatol 34(7):1590\u20131592","journal-title":"J Rheumatol"},{"key":"8632_CR32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/art.1780340126","volume":"34","author":"P Langevitz","year":"1991","unstructured":"Langevitz P, Mangire L, Urowitz M (1991) Accelerated nodulosis during azathioprine therapy. Arthritis Rheum 34:123\u2013124","journal-title":"Arthritis Rheum"},{"key":"8632_CR33","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s10067-005-0024-1","volume":"25","author":"A Rozin","year":"2006","unstructured":"Rozin A, Yigla M, Guralnik L et al (2006) Rheumatoid lung nodulosis and osteopathy with leflunomide therapy. J Clin Rheumatol 25:384\u2013388","journal-title":"J Clin Rheumatol"},{"issue":"6","key":"8632_CR34","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/01.rhu.0000147054.26777.43","volume":"10","author":"CL Mackley","year":"2004","unstructured":"Mackley CL, Ostrov BE, Loffredo MD (2004) Accelerated cutaneous nodulosis during infliximab therapy in a patient with rheumatoid arthritis. J Clin Rheumatol 10(6):336\u2013338","journal-title":"J Clin Rheumatol"},{"issue":"9","key":"8632_CR35","first-page":"1427","volume":"15","author":"M Couret","year":"1988","unstructured":"Couret M, Combe B, Chuong VT, Leroux JL, Blotman F, Sany J (1988) Rheumatoid nodulosis: report of two new cases and discussion of diagnostic criteria. J Rheumatol 15(9):1427\u20131430","journal-title":"J Rheumatol"},{"issue":"2","key":"8632_CR36","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.semarthrit.2006.04.006","volume":"36","author":"MS Genta","year":"2006","unstructured":"Genta MS, Genta RM, Gabay C (2006) Systemic rheumatoid vasculitis: a review. Semin Arthritis Rheum 36(2):88\u201398","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"8632_CR37","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/ard.62.6.587","volume":"62","author":"L Unger","year":"2003","unstructured":"Unger L, Kayser M, Nusslein HG (2003) Successful treatment of severe rheumatoid vasculitis by infliximab. Ann Rheum Dis 62(6):587\u2013588","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"8632_CR38","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1365-2133.2005.06520.x","volume":"152","author":"D Hirche","year":"2005","unstructured":"Hirche D, Rubbert A, Lunau L, Krieg T, Eming SA (2005) Successful treatment of refractory rheumatoid arthritis-associated leg ulcerations with adalimumab. Br J Dermatol 152(5):1062\u20131064","journal-title":"Br J Dermatol"},{"issue":"12","key":"8632_CR39","first-page":"2379","volume":"33","author":"IW Uthman","year":"2006","unstructured":"Uthman IW, Khamashta MA (2006) Livedo racemosa: a striking dermatological sign for the antiphospholipid syndrome. J Rheumatol 33(12):2379\u20132382","journal-title":"J Rheumatol"},{"issue":"5","key":"8632_CR40","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4103\/2229-5178.164493","volume":"6","author":"VV Sajjan","year":"2015","unstructured":"Sajjan VV, Lunge S, Swamy MB, Pandit AM (2015) Livedo reticularis: a review of the literature. Indian Dermatol Online J 6(5):315\u2013321","journal-title":"Indian Dermatol Online J"},{"issue":"8","key":"8632_CR41","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s10067-011-1727-0","volume":"30","author":"P Hartmann","year":"2011","unstructured":"Hartmann P, Mohokum M, Schlattmann P (2011) The association of Raynaud\u2019s syndrome with rheumatoid arthritis\u2014a meta-analysis. Clin Rheumatol 30(8):1013\u20131019","journal-title":"Clin Rheumatol"},{"issue":"6","key":"8632_CR42","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.jaad.2006.07.016","volume":"55","author":"D Wallach","year":"2006","unstructured":"Wallach D, Vignon-Pennamen MD (2006) From acute febrile neutrophilic dermatosis to neutrophilic disease: forty years of clinical research. J Am Acad Dermatol 55(6):1066\u20131071","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"8632_CR43","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.clindermatol.2013.11.004","volume":"32","author":"L Prat","year":"2014","unstructured":"Prat L, Bouaziz JD, Wallach D, Vignon-Pennamen MD, Bagot M (2014) Neutrophilic dermatoses as systemic diseases. Clin Dermatol 32(3):376\u2013388","journal-title":"Clin Dermatol"},{"issue":"1","key":"8632_CR44","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/MOH.0b013e32835ad132","volume":"20","author":"A Cl","year":"2013","unstructured":"Cl A, Cohen PR (2013) Acute febrile neutrophilic dermatosis (Sweet\u2019s syndrome). Curr Opin Hematol 20(1):26\u201335","journal-title":"Curr Opin Hematol"},{"issue":"3 Suppl2","key":"8632_CR45","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1016\/j.jaad.2005.11.1089","volume":"54","author":"PS Yamauchi","year":"2006","unstructured":"Yamauchi PS, Turner L, Lowe NJ, Gindi V, Jackson JM (2006) Treatment of recurrent Sweet\u2019s syndrome with coexisting rheumatoid arthritis with the tumor necrosis factor antagonist etanercept. J Am Acad Dermatol 54(3 Suppl2):S122\u2013S126","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"8632_CR46","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jaad.2013.06.023","volume":"69","author":"NM Rochet","year":"2013","unstructured":"Rochet NM, Chavan RN, Cappel MA, Wada DA, Gibson LE (2013) Sweet syndrome: clinical presentation, associations, and response to treatment in 77 patients. J Am Acad Dermatol 69(4):557\u2013564","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"8632_CR47","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.clindermatol.2015.05.003","volume":"33","author":"U Wollina","year":"2015","unstructured":"Wollina U (2015) Pyoderma gangrenosum\u2014a systemic disease? Clin Dermatol 33(5):527\u2013530","journal-title":"Clin Dermatol"},{"issue":"5","key":"8632_CR48","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/bjd.14691","volume":"175","author":"AV Marzano","year":"2016","unstructured":"Marzano AV, Borghi A, Meroni PL, Cugno M (2016) Pyoderma gangrenosum and its syndromic forms: evidence for a link with autoinflammation. Br J Dermatol 175(5):882\u2013891","journal-title":"Br J Dermatol"},{"issue":"3","key":"8632_CR49","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0190-9622(96)90428-4","volume":"34","author":"FC Powell","year":"1996","unstructured":"Powell FC, Daniel Su WP, Perry HO (1996) Pyoderma gangrenosum: classification and management. J Am Acad Dermatol 34(3):395\u2013409","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"8632_CR50","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jaad.2015.06.021","volume":"73","author":"SF Braswell","year":"2015","unstructured":"Braswell SF, Kostopoulos TC, Ortega-Loayza AG (2015) Pathophysiology of pyoderma gangrenosum (PG): an updated review. J Am Acad Dermatol 73(4):691\u2013698","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"8632_CR51","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1046\/j.1365-2133.2000.03565.x","volume":"142","author":"A MacAya","year":"2000","unstructured":"MacAya A, Servitje O, Jucgl\u00e0 A, Peyr\u00ed J (2000) Rheumatoid neutrophilic dermatitis associated with pyoderma gangrenosum. Br J Dermatol 142(6):1246\u20131248","journal-title":"Br J Dermatol"},{"issue":"4","key":"8632_CR52","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1067\/mjd.2003.58","volume":"48","author":"T Yamamoto","year":"2003","unstructured":"Yamamoto T, Matsunaga T, Nishioka K (2003) Rheumatoid neutrophilic dermatitis, rheumatoid papules, and rheumatoid nodules in a patient with seronegative rheumatoid arthritis. J Am Acad Dermatol 48(4):634\u2013635","journal-title":"J Am Acad Dermatol"},{"issue":"2 Suppl","key":"8632_CR53","first-page":"S94","volume":"51","author":"CI Lu","year":"2004","unstructured":"Lu CI, Yang CH, Hong HS (2004) A bullous neutrophilic dermatosis in a patient with severe rheumatoid arthritis and monoclonal IgA gammopathy. J Am Acad Dermatol 51(2 Suppl):S94\u2013S96","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"8632_CR54","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jbspin.2015.03.018","volume":"83","author":"R Andr\u00e9","year":"2016","unstructured":"Andr\u00e9 R, de Maleissye MF, Costantino F, Sohier P, Cl\u00e9rici T, Hayem G, Breban M (2016) Rheumatoid neutrophilic dermatitis. Joint Bone Spine. 83(3):359\u2013360","journal-title":"Joint Bone Spine."},{"issue":"8","key":"8632_CR55","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/DAD.0000000000000288","volume":"37","author":"I Coutinho","year":"2015","unstructured":"Coutinho I, Pereira N, Gouveia M, Cardoso JC, Tellechea O (2015) Interstitial granulomatous dermatitis: a clinicopathological study. Am J Dermatopathol 37(8):614\u2013619","journal-title":"Am J Dermatopathol"},{"issue":"3","key":"8632_CR56","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1590\/abd1806-4841.20153263","volume":"90","author":"IS Veronez","year":"2015","unstructured":"Veronez IS, Valente NY, Yasuda TH, Dantas FL, Kakizaki P, Cunha TA (2015) Interstitial granulomatous dermatitis: rare cutaneous manifestation of rheumatoid arthritis. An Bras Dermatol 90(3):391\u2013393","journal-title":"An Bras Dermatol"},{"issue":"4","key":"8632_CR57","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1365-2133.2011.10727.x","volume":"166","author":"A Peroni","year":"2012","unstructured":"Peroni A, Colato C, Schena D, Gisondi P, Girolomoni G (2012) Interstitial granulomatous dermatitis: a distinct entity with characteristic histological and clinical pattern. Br J Dermatol 166(4):775\u2013783","journal-title":"Br J Dermatol"},{"issue":"5","key":"8632_CR58","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/ced.12052","volume":"38","author":"FS Worsnop","year":"2013","unstructured":"Worsnop FS, Ostlere L (2013) Interstitial granulomatous dermatitis with arthritis presenting with the rope sign. Clin Exp Dermatol 38(5):564\u2013565","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"8632_CR59","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1067\/mjd.2002.124620","volume":"47","author":"OP Sanguenza","year":"2002","unstructured":"Sanguenza OP, Caudell MD, Mengesha YM, Davis LS, Barnes CJ, Griffin JE, Fleischer AB, Jorizzo JL (2002) Palisaded neutrophilic granulomatous dermatitis in rheumatoid arthritis. J Am Acad Dermatol 47(2):251\u2013257","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"8632_CR60","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.semarthrit.2004.06.001","volume":"34","author":"R Bremner","year":"2004","unstructured":"Bremner R, Simpson E, White CR Jr, Morrison L, Deodhar A (2004) Palisaded neutrophilic and granulomatous dermatitis: an unusual cutaneous manifestation of immune-mediated disorders. Semin Arthritis Rheum 34(3):610\u2013616","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"8632_CR61","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/j.1365-2133.1997.tb01559.x","volume":"137","author":"C Michel","year":"1997","unstructured":"Michel C, Cribier B, Sibilia J, Kuntz JL, Grosshans E (1997) Nail abnormalities in rheumatoid arthritis. Br J Dermatol 137(6):958\u2013962","journal-title":"Br J Dermatol"},{"issue":"5","key":"8632_CR62","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0190-9622(83)70085-X","volume":"8","author":"JL Jorizzo","year":"1983","unstructured":"Jorizzo JL, Gonzalez EB, Daniels JC (1983) Red lunulae in a patient with rheumatoid arthritis. J Am Acad Dermatol 8(5):711\u2013714","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"8632_CR63","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0733-8635(18)30886-6","volume":"3","author":"CR Daniel","year":"1985","unstructured":"Daniel CR, Sams WM Jr, Scher RK (1985) Nails in systemic disease. Dermatol Clin 3(3):465\u2013483","journal-title":"Dermatol Clin"},{"issue":"10","key":"8632_CR64","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/ard.44.10.671","volume":"44","author":"EN Grant","year":"1985","unstructured":"Grant EN, Bellamy N, Buchanan WW, Grace EM, O\u2019Leary S (1985) Statistical reappraisal of the clinical significance of nail beading in rheumatoid arthritis. Ann Rheum Dis 44(10):671\u2013675","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"8632_CR65","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1067\/mjd.2002.117394","volume":"46","author":"F Rongioletti","year":"2002","unstructured":"Rongioletti F, Cutolo M, Bondavalli P, Rebora A (2002) Acral localized acquired cutis laxa associated with rheumatoid arthritis. J Am Acad Dermatol 46(1):128\u2013130","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"8632_CR66","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1067\/mjd.2002.122759","volume":"46","author":"CE Grattan","year":"2002","unstructured":"Grattan CE, Sabroe RA, Greaves MW (2002) Chronic urticaria. J Am Acad Dermatol 46(5):645\u2013657","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"8632_CR67","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/00000372-200008000-00007","volume":"22","author":"C Tomasini","year":"2000","unstructured":"Tomasini C, Soro E, Pippione M (2000) Angioendotheliomatosis in a woman with rheumatoid arthritis. Am J Dermatopathol 22(4):334\u2013338","journal-title":"Am J Dermatopathol"},{"issue":"3","key":"8632_CR68","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.semarthrit.2010.04.003","volume":"40","author":"AN Collamer","year":"2010","unstructured":"Collamer AN, Battafarano DF (2010) Tumor necrosis factor antagonist therapy: clinical features and possible immunopathogenesis. Semin Arthritis Rheum 40(3):233\u2013240","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"8632_CR69","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/annrheumdis-2016-209285","volume":"76","author":"LK Mercer","year":"2017","unstructured":"Mercer LK, Askling J, Raaschou P, Dixon WG, Dreyer L, Hetland ML, Strangfeld A, Zink A8, Mariette X, Finckh A, Canhao H, Iannone F, Zavada J, Morel J, Gottenberg JE, Hyrich KL, Listing J (2017) Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers. Ann Rheum Dis 76(2):386\u2013391","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"8632_CR70","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s40744-016-0040-4","volume":"3","author":"G Giancane","year":"2016","unstructured":"Giancane G, Consolaro A, Lanni S, Dav\u00ec S, Schiappapietra B, Ravelli A (2016) Juvenile idiopathic arthritis: diagnosis and treatment. Rheumatol Ther 3(2):187\u2013207","journal-title":"Rheumatol Ther"},{"issue":"2","key":"8632_CR71","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.pcl.2012.03.014","volume":"59","author":"PJ Gowdie","year":"2012","unstructured":"Gowdie PJ, Tse SML (2012) Juvenile idiopathic arthritis. Pediatr Clin N Am 59(2):301\u2013327","journal-title":"Pediatr Clin N Am"},{"issue":"6","key":"8632_CR72","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3899\/jrheum.141261","volume":"42","author":"F Minoia","year":"2015","unstructured":"Minoia F, Davi S, Horne A, Bovis F, Demirkaya E, Akikusa J et al (2015) Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Rheumatol 42(6):994\u20131001","journal-title":"J Rheumatol"},{"issue":"2","key":"8632_CR73","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P et al (2004) International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31(2):390\u2013392","journal-title":"J Rheumatol"},{"issue":"6","key":"8632_CR74","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1309\/AJCPZE77UAPSMDCD","volume":"144","author":"AR Larson","year":"2015","unstructured":"Larson AR, Laga AC, Granter SR (2015) The spectrum of histopathologic findings in cutaneous lesions in patients with Still disease. Am J Clin Pathol 144(6):945\u2013951","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"8632_CR75","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.semarthrit.2016.10.008","volume":"46","author":"R Davies","year":"2017","unstructured":"Davies R, Gaynor D, Hyrich KL, Pain CE (2017) Efficacy of biologic therapy across individual juvenile idiopathic arthritis subtypes: a systematic review. Semin Arthritis Rheum 46(5):584\u2013593","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"8632_CR76","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.clim.2015.06.005","volume":"160","author":"M Shimizu","year":"2015","unstructured":"Shimizu M, Nakagishi Y, Inoue N, Mizuta M, Ko G, Saikawa Y, Kubota T, Yamasaki Y, Takei S, Yachie A (2015) Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Clin Immunol 160(2):277\u2013281","journal-title":"Clin Immunol"},{"issue":"5","key":"8632_CR77","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s40272-015-0137-1","volume":"17","author":"IM Bronckers","year":"2015","unstructured":"Bronckers IM, Paller AS, van Geel MJ, van de Kerkhof PC, Seyger MM (2015) Psoriasis in children and adolescents: diagnosis, management and comorbidities. Paediatr Drugs 17(5):373\u2013384","journal-title":"Paediatr Drugs"},{"issue":"6","key":"8632_CR78","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jaad.2009.06.048","volume":"62","author":"ME Jager de","year":"2010","unstructured":"de Jager ME, de Jong EM, van de Kerkhof PC et al (2010) Efficacy and safety of treatments for childhood psoriasis: a systematic literature review. J Am Acad Dermatol 62(6):1013\u20131030","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"8632_CR79","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1136\/annrheumdis-2015-208730","volume":"75","author":"A Sepriano","year":"2016","unstructured":"Sepriano A, Landewe R, van der Heijde D, Sieper J, Akkoc N, Brandt J et al (2016) Predictive validity of the ASAS classification criteria for axial and peripheral spondyloarthritis after follow-up in the ASAS cohort: a final analysis. Ann Rheum Dis 75(6):1034\u20131042","journal-title":"Ann Rheum Dis"},{"key":"8632_CR80","unstructured":"Kataria RK, D.O., Brent LH (2004) Spondyloarthropathies. Am Fam Physician 69(12):2853\u20132860"},{"issue":"9783","key":"8632_CR81","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(11)60071-8","volume":"377","author":"M Dougados","year":"2011","unstructured":"Dougados M, Baeten D (2011) Spondyloarthritis. Lancet 377(9783):2127\u20132137","journal-title":"Lancet"},{"issue":"9","key":"8632_CR82","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/rheumatology\/kep146","volume":"48","author":"D Elewaut","year":"2009","unstructured":"Elewaut D, Matucci-Cerinic M (2009) Treatment of ankylosing spondylitis and extra-articular manifestations in everyday rheumatology practice. Rheumatology 48(9):1029\u20131035","journal-title":"Rheumatology"},{"issue":"4","key":"8632_CR83","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/BOR.0000000000000069","volume":"26","author":"N Yeremenko","year":"2014","unstructured":"Yeremenko N, Paramarta JE, Baeten D (2014) The interleukin-23\/interleukin-17 immune axis as a promising new target in the treatment of spondyloarthritis. Curr Opin Rheumatol 26(4):361\u2013370","journal-title":"Curr Opin Rheumatol"},{"issue":"8","key":"8632_CR84","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H et al (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54(8):2665\u20132673","journal-title":"Arthritis Rheum"},{"issue":"2","key":"8632_CR85","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10067-013-2412-2","volume":"33","author":"H Maldonado Ficco","year":"2014","unstructured":"Maldonado Ficco H, Citera G, Maldonado Cocco JA (2014) Prevalence of psoriatic arthritis in psoriasis patients according to newer classification criteria. Clin Rheumatol 33(2):243\u2013246","journal-title":"Clin Rheumatol"},{"issue":"2","key":"8632_CR86","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.rdc.2012.05.005","volume":"38","author":"DD Gladman","year":"2012","unstructured":"Gladman DD (2012) Early psoriatic arthritis. Rheum Dis Clin N Am 38(2):373\u2013386","journal-title":"Rheum Dis Clin N Am"},{"issue":"5","key":"8632_CR87","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.clindermatol.2006.07.006","volume":"24","author":"WA Myers","year":"2006","unstructured":"Myers WA, Gottlieb AB, Mease P (2006) Psoriasis and psoriatic arthritis: clinical features and disease mechanisms. Clin Dermatol 24(5):438\u2013447","journal-title":"Clin Dermatol"},{"issue":"6","key":"8632_CR88","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jbspin.2005.10.006","volume":"72","author":"P Goupille","year":"2005","unstructured":"Goupille P (2005) Psoriatic arthritis. Joint Bone Spine 72(6):466\u2013470","journal-title":"Joint Bone Spine"},{"key":"8632_CR89","doi-asserted-by":"crossref","unstructured":"Helliwell PS, Taylor WJ (2005) Classification and diagnostic criteria for psoriatic arthritis. Ann Rheum Dis. 64(Suppl 2):ii3-8","DOI":"10.1136\/ard.2004.032318"},{"key":"8632_CR90","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jaut.2016.10.009","volume":"76","author":"SP Raychaudhuri","year":"2017","unstructured":"Raychaudhuri SP, Wilken R, Sukhov AC, Raychaudhuri SK, Maverakis E (2017) Management of psoriatic arthritis: early diagnosis, monitoring of disease severity and cutting edge therapies. J Autoimmun 76:21\u201337","journal-title":"J Autoimmun"},{"key":"8632_CR91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000232301","volume":"38","author":"M Meier","year":"2009","unstructured":"Meier M, Sheth PB (2009) Clinical spectrum and severity of psoriasis. Curr Probl Dermatol 38:1\u201320","journal-title":"Curr Probl Dermatol"},{"issue":"Suppl 2:ii1","key":"8632_CR92","first-page":"8","volume":"64","author":"RG Langley","year":"2005","unstructured":"Langley RG, Krueger GG, Griffiths CE (2005) Psoriasis: epidemiology, clinical features and quality of life. Ann Rheum Dis 64(Suppl 2:ii1):8\u201323 discussion ii24-5","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"8632_CR93","doi-asserted-by":"crossref","first-page":"594","DOI":"10.4103\/0378-6323.45100","volume":"74","author":"SK Malhotra","year":"2008","unstructured":"Malhotra SK, Mehta V (2008) Role of stressful life events in induction or exacerbation of psoriasis and chronic urticaria. Indian J Dermatol Venereol Leprol 74(6):594\u2013599","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"4\u20135","key":"8632_CR94","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.autrev.2014.01.008","volume":"13","author":"SK Raychaudhuri","year":"2014","unstructured":"Raychaudhuri SK, Maverakis E, Raychaudhuri SP (2014) Diagnosis and classification of psoriasis. Autoimmun Rev 13(4\u20135):490\u2013495","journal-title":"Autoimmun Rev"},{"issue":"6 Pt 1","key":"8632_CR95","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/0190-9622(90)70155-B","volume":"22","author":"JD Bernhard","year":"1990","unstructured":"Bernhard JD (1990) Auspitz sign is not sensitive or specific for psoriasis. J Am Acad Dermatol 22(6 Pt 1):1079\u20131081","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"8632_CR96","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1001\/archderm.1976.01630310017003","volume":"112","author":"NS Penneys","year":"1976","unstructured":"Penneys NS, Ziboh V, Simon P (1976) Pathogenesis of Woronoff ring in psoriasis. Arch Dermatol 112(7):955\u2013957","journal-title":"Arch Dermatol"},{"issue":"3","key":"8632_CR97","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1067\/mjd.2001.110876","volume":"44","author":"L Naldi","year":"2001","unstructured":"Naldi L, Peli L, Parazzini F, Carrel CF, Psoriasis Study Group of the Italian Group for Epidemiological Research in Dermatology (2001) Family history of psoriasis, stressful life events, and recent infectious disease are risk factors for a first episode of acute guttate psoriasis: results of a case-control study. J Am Acad Dermatol 44(3):433\u2013438","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"8632_CR98","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1525-1470.2002.00026.x","volume":"19","author":"PB Liao","year":"2002","unstructured":"Liao PB, Rubinson R, Howard R, Sanchez G, Frieden IJ (2002) Annular pustular psoriasis\u2014most common form of pustular psoriasis in children: report of 3 cases and review of the literature. Pediatr Dermatol 19(1):19\u201325","journal-title":"Pediatr Dermatol"},{"issue":"7","key":"8632_CR99","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa1013068","volume":"365","author":"S Marrakchi","year":"2011","unstructured":"Marrakchi S, Guigue P, Renshaw BR, Puel A, Pei XY, Fraitag S et al (2011) Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med 365(7):620\u2013628","journal-title":"N Engl J Med"},{"issue":"5","key":"8632_CR100","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ajhg.2012.03.012","volume":"90","author":"CT Jordan","year":"2012","unstructured":"Jordan CT, Cao L, Roberson ED, Pierson KC, Yang CF, Joyce CE et al (2012) PSORS2 is due to mutations in CARD14. Am J Hum Genet 90(5):784\u2013795","journal-title":"Am J Hum Genet"},{"issue":"5","key":"8632_CR101","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.ajhg.2014.04.005","volume":"94","author":"N Setta-Kaffetzi","year":"2014","unstructured":"Setta-Kaffetzi N, Simpson MA, Navarini AA, Patel VM, Lu HC, Allen MH et al (2014) AP1S3 mutations are associated with pustular psoriasis and impaired Toll-like receptor 3 trafficking. Am J Hum Genet 94(5):790\u2013797","journal-title":"Am J Hum Genet"},{"issue":"6 Suppl 1","key":"8632_CR102","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1590\/abd1806-4841.20132134","volume":"88","author":"RN Kondo","year":"2013","unstructured":"Kondo RN, Ara\u00fajo FM, Pereira AM, Lopes VCH, Martins LM (2013) Pustular psoriasis of pregnancy (impetigo herpetiformis)\u2014case report. An Bras Dermatol 88(6 Suppl 1):186\u2013189","journal-title":"An Bras Dermatol"},{"issue":"6","key":"8632_CR103","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s40265-016-0564-5","volume":"76","author":"MC Pasch","year":"2016","unstructured":"Pasch MC (2016) Nail psoriasis: a review of treatment options. Drugs 76(6):675\u2013705","journal-title":"Drugs"},{"issue":"1","key":"8632_CR104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2005.07.073","volume":"57","author":"MM Jiaravuthisan","year":"2007","unstructured":"Jiaravuthisan MM, Sasseville D, Vender RB, Murphy F, Muhn CY (2007) Psoriasis of the nail: anatomy, pathology, clinical presentation, and review of the literature on therapy. J Am Acad Dermatol 57(1):1\u201327","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"8632_CR105","first-page":"177","volume":"149","author":"A Patrizi","year":"2014","unstructured":"Patrizi A, Venturi M, Scorzoni R, Pazzaglia M, Malavolta N, Bardazzi F (2014) Nail dystrophies, scalp and intergluteal\/perianal psoriatic lesions: risk factors for psoriatic arthritis in mild skin psoriasis? G Ital Dermatol Venereol 149(2):177\u2013184","journal-title":"G Ital Dermatol Venereol"},{"issue":"2","key":"8632_CR106","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/art.24172","volume":"61","author":"FC Wilson","year":"2009","unstructured":"Wilson FC, Icen M, Crowson CS, McEvoy MT, Gabriel SE, Kremers HM (2009) Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum 61(2):233\u2013239","journal-title":"Arthritis Rheum"},{"issue":"4","key":"8632_CR107","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jaad.2008.12.032","volume":"60","author":"A Menter","year":"2009","unstructured":"Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb A, Koo JY, Lebwohl M, Lim HW, Van Voorhees AS, Beutner KR, Bhushan R, American Academy of Dermatology (2009) Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol 60(4):643\u2013659","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"8632_CR108","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jaad.2009.08.026","volume":"62","author":"A Menter","year":"2010","unstructured":"Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb A, Koo JY, Lebwohl M, Lim HW, Van Voorhees AS, Beutner KR, Bhushan R (2010) Guidelines of care for the management of psoriasis and psoriatic arthritis: section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy. J Am Acad Dermatol 62(1):114\u2013135","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"8632_CR109","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jaad.2009.03.027","volume":"61","author":"A Menter","year":"2009","unstructured":"Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb AB, Koo JY, Lebwohl M, Lim HW, Van Voorhees AS, Beutner KR, Bhushan R (2009) Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol 61(3):451\u2013485","journal-title":"J Am Acad Dermatol"},{"key":"8632_CR110","doi-asserted-by":"publisher","unstructured":"Smith CH, Jabbar-Lopez ZK, Yiu ZZ, Bale T, Burden AD, Coates LC, Cruickshank M, Hadoke T, MacMahon E, Murphy R, Nelson-Piercy C, Owen CM, Parslew R, Peleva E, Pottinger E, Samarasekera EJ, Stoddart J, Strudwicke C, Venning V, Warren RB, Exton LS, Mohd Mustapa MF (2017) British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017. Br J Dermatol May 17. doi: 10.1111\/bjd.15665","DOI":"10.1111\/bjd.15665"},{"issue":"4","key":"8632_CR111","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1159\/000445681","volume":"232","author":"AG Kolios","year":"2016","unstructured":"Kolios AG, Yawalkar N, Anliker M, Boehncke WH, Borradori L, Conrad C, Gilliet M, H\u00e4usermann P, Itin P, Laffitte E, Mainetti C, French LE, Navarini AA (2016) Swiss S1 guidelines on the systemic treatment of psoriasis vulgaris. Dermatology 232(4):385\u2013406","journal-title":"Dermatology"},{"issue":"12","key":"8632_CR112","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1111\/jdv.13354","volume":"29","author":"A Nast","year":"2015","unstructured":"Nast A, Gisondi P, Ormerod AD, Saiag P, Smith C, Spuls PI, Arenberger P, Bachelez H, Barker J, Dauden E, de Jong EM, Feist E, Jacobs A, Jobling R, Kem\u00e9ny L, Maccarone M, Mrowietz U, Papp KA, Paul C, Reich K, Rosumeck S, Talme T, Thio HB, van de Kerkhof P, Werner RN, Yawalkar N (2015) European S3\u2014guidelines on the systemic treatment of psoriasis vulgaris\u2014update 2015\u2014short version\u2014EDF in cooperation with EADV and IPC. J Eur Acad Dermatol Venereol 29(12):2277\u20132294","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"8632_CR113","volume-title":"Psoriasis: assessment and management of psoriasis","author":"National Clinical Guideline Centre (UK)","year":"2012","unstructured":"National Clinical Guideline Centre (UK) (2012) Psoriasis: assessment and management of psoriasis. Royal College of Physicians (UK), London"},{"issue":"6","key":"8632_CR114","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ejim.2011.06.006","volume":"22","author":"AE Maghrauoui","year":"2011","unstructured":"Maghrauoui AE (2011) Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications. Eur J of Intern Med 22(6):554\u2013560","journal-title":"Eur J of Intern Med"},{"issue":"9313","key":"8632_CR115","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0140-6736(02)08215-6","volume":"359","author":"J Braun","year":"2002","unstructured":"Braun J, Brandt J, Listing J, Zink A, Alten R, Golder W et al (2002) Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 359(9313):1187\u20131193","journal-title":"Lancet"},{"issue":"7","key":"8632_CR116","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.3899\/jrheum.081122","volume":"36","author":"L Barra","year":"2009","unstructured":"Barra L, Pope JE, Payne M (2009) Real-world anti-tumor necrosis factor treatment in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: cost-effectiveness based on number needed to treat to improve health assessment questionnaire. J Rheumatol 36(7):1421\u20131428","journal-title":"J Rheumatol"},{"issue":"1","key":"8632_CR117","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jaad.2008.02.047","volume":"59","author":"IB Wu","year":"2008","unstructured":"Wu IB, Schwartz RA (2008) Reiter\u2019s syndrome: the classic triad and more. J Am Acad Dermatol 59(1):113\u2013121","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"8632_CR118","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.clindermatol.2015.05.004","volume":"33","author":"E Generali","year":"2015","unstructured":"Generali E, Ceribelli A, Massarotti M, Cantarini L, Selmi C (2015) Seronegative reactive spondyloarthritis and the skin. Clin Dermatol 33(5):531\u2013537","journal-title":"Clin Dermatol"},{"issue":"4\u20135","key":"8632_CR119","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.autrev.2014.01.005","volume":"13","author":"C Selmi","year":"2014","unstructured":"Selmi C, Gershwin ME (2014) Diagnosis and classification of reactive arthritis. Autoimmun Rev 13(4\u20135):546\u2013549","journal-title":"Autoimmun Rev"},{"issue":"3","key":"8632_CR120","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.berh.2011.01.018","volume":"25","author":"T Hannu","year":"2011","unstructured":"Hannu T (2011) Reactive arthritis. Best Pract Res Clin Rheumatol 25(3):347\u2013357","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"5","key":"8632_CR121","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/art.27394","volume":"62","author":"JD Carter","year":"2010","unstructured":"Carter JD, Espinoza LR, Inman RD, Sneed KB, Ricca LR, Vasey FB et al (2010) Combination antibiotics as a treatment for chronic chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial. Arthritis Rheum 62(5):1298\u20131307","journal-title":"Arthritis Rheum"},{"key":"8632_CR122","doi-asserted-by":"crossref","unstructured":"Marzano AV, Borghi A, Stadnicki A, Crosti C, Cugno M Cutaneous manifestations in patients with inflammatory bowel diseases: pathophysiology, clinical features, and therapy. Inflamm Bowel Dis 20(1):213\u2013227","DOI":"10.1097\/01.MIB.0000436959.62286.f9"},{"issue":"11","key":"8632_CR123","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/cup.12777","volume":"43","author":"JS Ko","year":"2016","unstructured":"Ko JS, Uberti G, Napekoski K, Patil DT, Billings SD (2016) Cutaneous manifestations in inflammatory bowel disease: a single institutional study of non-neoplastic biopsies over 13\u00a0years. J Cutan Pathol 43(11):946\u2013955","journal-title":"J Cutan Pathol"},{"issue":"1","key":"8632_CR124","first-page":"21","volume":"25","author":"Z Pellicer","year":"2012","unstructured":"Pellicer Z, Santiago JM, Rodriguez A, Alonso V, Ant\u00f3n R, Bosca MM (2012) Management of cutaneous disorders related to inflammatory bowel disease. Ann Gastroenterol 25(1):21\u201326","journal-title":"Ann Gastroenterol"},{"issue":"Suppl 4","key":"8632_CR125","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2036.2004.02055.x","volume":"20","author":"FT Veloso","year":"2004","unstructured":"Veloso FT (2004) Review article: skin complications associated with inflammatory bowel disease. Aliment Pharmacol Ther 20(Suppl 4):50\u201353","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"8632_CR126","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1097\/MIB.0000000000000392","volume":"21","author":"SR Vavricka","year":"2015","unstructured":"Vavricka SR, Schoepfer A, Scharl M, Lakatos PL, Navarini A, Rogler G (2015) Extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis 21(8):1982\u20131992","journal-title":"Inflamm Bowel Dis"},{"key":"8632_CR127","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.semarthrit.2012.05.006","volume":"42","author":"MT Nguyen","year":"2012","unstructured":"Nguyen MT, Borchers A, Selmi C, Naguwa SM, Cheema G, Gershwin ME (2012) The SAPHO syndrome. Semin Arthritis Rheum 42:254\u2013265","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"8632_CR128","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.autrev.2008.07.030","volume":"8","author":"M Govoni","year":"2009","unstructured":"Govoni M, Colina M, Massara A, Trotta F (2009) SAPHO syndrome and infections. Autoimmun Rev 8(3):256\u2013259","journal-title":"Autoimmun Rev"},{"issue":"6","key":"8632_CR129","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11926-016-0583-y","volume":"18","author":"D Firinu","year":"2016","unstructured":"Firinu D, Garcia-Larsen V, Manconi PE, Del Giacco SR (2016) SAPHO syndrome: current developments and approaches to clinical treatment. Curr Rheumatol Rep 18(6):35","journal-title":"Curr Rheumatol Rep"},{"issue":"9813","key":"8632_CR130","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0140-6736(11)60321-8","volume":"379","author":"HC Williams","year":"2012","unstructured":"Williams HC, Dellavalle RP, Garner S (2012) Acne vulgaris. Lancet 379(9813):361\u2013372","journal-title":"Lancet"},{"key":"8632_CR131","doi-asserted-by":"publisher","unstructured":"Wendling D, Aubin F, Verhoeven F, Prati C (2017) IL-23\/Th17 targeted therapies in SAPHO syndrome. A case series. Joint Bone Spine. Pii: S1297-319X(17)30107-0. doi: 10.1016\/j.jbspin.2017.05.016","DOI":"10.1016\/j.jbspin.2017.05.016"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-017-8632-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-017-8632-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-017-8632-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T14:18:38Z","timestamp":1569939518000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-017-8632-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,27]]},"references-count":131,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["8632"],"URL":"https:\/\/doi.org\/10.1007\/s12016-017-8632-5","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,27]]}}}